Los Angeles Capital Management
AGIO icon

Los Angeles Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Los Angeles Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$669K Buy
18,028
+17,078
+1,798% +$518K ﹤0.01% 836
2026
Q1 		$32.1K Buy
950
+650
+217% +$18.4K ﹤0.01% 1601
2025
Q4 		$13K Buy
+300
New +$10.5K ﹤0.01% 2000

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Los Angeles Capital Management's AGIO Position: Q2 2026 in Review

Los Angeles Capital Management increased its Agios Pharmaceuticals (AGIO) stake by 1,798% in Q2 2026, buying an estimated $518K and bringing the position to 18,028 shares worth $669K. The position accounts for ﹤0.01% of the portfolio, ranked #836.

Los Angeles Capital Management first reported a position in AGIO in Q4 2025 and has held it in 3 quarters since. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Los Angeles Capital Management held 18,028 shares of Agios Pharmaceuticals worth $669K as of Q2 2026.
  • Los Angeles Capital Management bought 17,078 Agios Pharmaceuticals shares in Q2 2026, an estimated $518K.
  • Agios Pharmaceuticals made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #836 holding.
  • Los Angeles Capital Management first reported a position in Agios Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.